First report of IMI-1-producing colistin-resistant Enterobacter clinical isolate in Ireland, March 2013.

Citation data:

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, ISSN: 1560-7917, Vol: 18, Issue: 31

Publication Year:
2013
Usage 115
Downloads 67
Abstract Views 48
Captures 26
Readers 26
Citations 10
Citation Indexes 10
Repository URL:
http://hdl.handle.net/10147/302269
PMID:
23929227
Author(s):
T. W. Boo; J. King; E. McGrath; N. O'Connell; L. Power; M. O'Connor; R. Hill; K. L. Hopkins; N. Woodford
Publisher(s):
Euro surveillance : bulletin Européen sur les maladies transmissibles = European communicable disease bulletin
Tags:
Medicine; Immunology and Microbiology
article description
We report the first case in Ireland of an IMI-1 carbapenemase-producing Enterobacter asburiae, which was resistant to both colistin and fosfomycin. The circumstances under which this isolate was acquired were unclear. Several reports of IMI-producing Enterobacter spp. have emerged in recent years, and colistin resistance in Enterobacteriaceae is also increasingly reported. Laboratories should be aware of the unusual antibiograms of IMI-producing isolates.